Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on chiral catalyst. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel chiral phosphoric acid catalyzed synthesis of N-N axis pyrroles. High yield, mild conditions, suitable for pharmaceutical intermediate manufacturing.
Patent CN111848322B details a novel organocatalytic resolution for axially chiral oxindole-substituted styrenes, offering high enantioselectivity and mild conditions for pharmaceutical intermediate manufacturing.
Patent CN107698590B details a novel asymmetric [3+2] cyclization for chiral carbocyclic purine nucleosides, offering high yields and enantioselectivity for reliable pharmaceutical intermediate supply.
Patent CN114920775B introduces a novel axial chiral bisindole catalyst offering high enantioselectivity and mild conditions for scalable pharmaceutical intermediate manufacturing.
Patent CN111777637B discloses a novel oxindole-derived phosphine catalyst enabling mild asymmetric cyclizations with excellent yields and supply chain stability.
Advanced synthesis of spiro quaternary ammonium salts via kinetic resolution. Offers superior enantioselectivity for amino acid synthesis with scalable industrial processes.
Patent CN107936025B reveals a metal-free NHC catalytic route for high-purity chiral pyrazolidinones, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN111848322B details a novel chiral phosphoric acid catalyzed resolution for axially chiral oxindole-substituted styrenes, offering high enantioselectivity and mild conditions for pharmaceutical intermediate manufacturing.
Novel synthesis method for high-purity chiral intermediates. Offers significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN111848322B details a novel chiral phosphoric acid resolution method for axially chiral oxindole-substituted styrenes, offering high enantioselectivity and mild conditions for pharmaceutical manufacturing.
Patent CN114920775B reveals high-selectivity catalyst synthesis. Offers cost reduction in pharmaceutical manufacturing and reliable supply chain solutions.
Discover novel axial chiral oxindole-derived styrene phosphine catalysts from patent CN111777637B. Enables asymmetric cyclization with mild conditions and scalable synthesis for fine chemical manufacturing.
Discover advanced axial chiral styrene tertiary amine thiourea catalysts offering superior enantioselectivity and mild reaction conditions for pharmaceutical intermediate manufacturing.
Patent CN112916042B discloses a robust tetramethylspirodihydroindene catalyst enabling high enantioselectivity in glycine alkylations, offering cost-effective API manufacturing solutions.
Patent CN110452150B details a mild, one-step synthesis of axial chiral indole-naphthalenes with high enantioselectivity, offering cost-effective solutions for chiral catalyst manufacturing.
Patent CN105056991B reveals spirocyclic phosphazene catalysts enabling high ee asymmetric synthesis. Offers cost reduction and scalable supply for pharma intermediates.
Patent CN117720537B reveals novel catalyst enabling high-purity asymmetric synthesis with reduced costs and scalable supply chain reliability for global buyers.
Patent CN114524701B reveals a novel organocatalytic route for N-N axis chiral pyrroles with high cytotoxicity, offering cost-effective API intermediate manufacturing solutions.
Patent CN114524701B reveals a novel chiral phosphoric acid catalyzed route for N-N axis chiral pyrroles with high enantioselectivity and cytotoxic activity.
Patent CN112574107B reveals a streamlined Pd-catalyzed C-H activation route for high-purity atropisomeric intermediates, offering significant supply chain advantages.